Meeting
2016 ASCO Annual Meeting
Combined effect of obesity and comorbidity on toxicity of adjuvant chemotherapy for breast cancer (BC).
Authors
Ana Fernandez Sanchez
Hospital Universitario Morales Meseguer, Murcia, Spain
Ana Fernandez Sanchez , Alejandra Ivars Rubio , Pilar de la Morena , Elisa Garcia-Garre , Elena García-Martínez , Maria Angeles Vicente , Edgar Urrego , Enrique Gonzalez-Billalabeitia , Francisco Ayala
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer—Triple-Negative/Cytotoxics/Local Therapy
Track
Breast Cancer
Sub Track
Cytotoxic Chemotherapy
Citation
J Clin Oncol 34, 2016 (suppl; abstr 1036)
DOI
10.1200/JCO.2016.34.15_suppl.1036
Abstract #
1036
Poster Bd #
141
Abstract Disclosures
Similar Posters
Poster
2016 ASCO Annual Meeting
Acute care use among women receiving adjuvant chemotherapy for breast cancer.
First Author: Kathryn Jean Ruddy
Poster
2013 ASCO Annual Meeting
Antiemetic efficacy of transcutaneous electrical nerve stimulation (TENS) at pericardium 6 acupuncture point (P6) in the treatment of chemotherapy-induced delayed nausea and vomiting (CINV) in stage I to III breast cancer patients during adjuvant/neoadjuvant chemotherapy (Ad/nAd).
First Author: Jean Yared
Poster
2022 ASCO Annual Meeting
CT scan versus bioelectrical impedance spectrometry sarcopenia assessment to predict chemotherapy toxicity in early breast cancer.
First Author: Gabriel Aleixo
Poster
2021 ASCO Annual Meeting
Assessing the risk of severe post-treatment (tx) cancer-related fatigue (CRF) among breast cancer survivors (BCS) in the CANcer TOxicity (CANTO) cohort.
First Author: Antonio Di Meglio